FDA M-CERSI AI workshop highlights future FDA comment period on AI in drug development | Hogan Lovells

The U.S. Food and Drug Administration (FDA) – in collaboration with the University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI) – recently hosted a...

Related Keywords

Tala Fakhouri ,Hogan Lovells ,Matthew Diamond ,Duke Robertj Margolis ,Digital Health Technologies Dhts ,Digital Health Excellence ,National Institute Of Standards ,Chief Medical Officer ,Digital Health ,National Institute ,Change Control ,Machine Learning Practice ,Medical Device ,Associate Director ,Policy Analysis ,Drug Evaluation ,Health Policy ,Digital Health Technologies ,Support Clinical Trials ,Drug Development ,Drug Omnibus Reform Act ,